IP Verse

King patent opposition analysis

The comprehensive analysis of King opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by King

Stay updated with the latest patent oppositions filed by King

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4338805
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDFeb 26, 2026ELKINGTON AND FIFE
EP4342546
Methods Of Reducing The Risk Of A Cardiovascular Event In A Subject On Statin TherapyAMARIN PHARMACEUTICALS IRELANDFeb 25, 2026ELKINGTON AND FIFE
EP3658140
Combinations Of A 4-Pyrimidinesulfamide Derivative With Active Ingredients For The Treatment Of Endothelin Related DiseasesIDORSIA PHARMACEUTICALSFeb 13, 2026ELKINGTON AND FIFE
EP3411021
New Use Of A Combination Of Sacubitril And ValsartanNOVARTISFeb 12, 2026GENERICS UK
EP3435996
Methods Of Treatment Of Cholestatic DiseasesGENFITJan 30, 2026GENERICS UK
EP3773013
Insulin Control In Overweight Or Obese Adult During Life Time InterventionNUTRICIAJan 29, 2026NESTLE
EP4212152
Sacubitril-Valsartan Dosage Regimen For Treating Heart FailureNOVARTISJan 28, 2026GENERICS UK
EP3411406
Multispecific Antigen-Binding Molecule With Improved Internalization CharacteristicsGENMABJan 9, 2026ELKINGTON AND FIFE
EP3716979
Combination Of A 4-Pyrimidinesulfamide Derivative With An Sglt-2 Inhibitor For The Treatment Of Endothelin Related DiseasesIDORSIA PHARMACEUTICALSJan 8, 2026ELKINGTON AND FIFE
EP3923890
Absorbent ArticleESSITY HYGIENE AND HEALTH AKTIEBOLAGJan 2, 2026THE PROCTER & GAMBLE

Top clients of King

Top companies who are the clients of King

CompanyTotal
GENERICS UK133
ELKINGTON AND FIFE89
TEVA PHARMACEUTICALS41
NESTLE38
SANDOZ38
THE PROCTER & GAMBLE33
COOKE26
POLPHARMA15
SANOFI11
GILLARD8